Aquestive Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $163.9M | $57.4M | $23.9M |
| FY2024 | $161.6M | $101.4M | $71.5M |
| FY2025 | $194.1M | $160.4M | $121.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $163.9M | $57.4M | $23.9M |
| FY2024 | $161.6M | $101.4M | $71.5M |
| FY2025 | $194.1M | $160.4M | $121.2M |